Page 43 - manuscript_ijb05590
P. 43

Markers in Gynecologic Cancer Using Microfluidic Devices: A Pilot Study. Int J
                        Mol Sci. 2023;24(3):2300. doi:10.3390/ijms24032300


                   127. Ayuso JM, Virumbrales-Muñoz M, Lang JM, Beebe DJ. A role for microfluidic
                        systems in precision medicine. Nat Commun. 2022;13:3086. doi:10.1038/s41467-
                        022-30384-7


                   128. Xu J, Wan R, Cai Y, et al. Circulating tumor DNA-based stratification strategy for
                        chemotherapy plus PD-1 inhibitor in advanced non-small-cell lung cancer. Cancer
                        Cell. 2024;42(9):1598-1613.e4. doi:10.1016/j.ccell.2024.08.013

                   129. Jamshidi A, Liu MC, Klein EA, et al. Evaluation of cell-free DNA approaches for
                        multi-cancer  early  detection.  Cancer  Cell.  2022;40(12):1537-1549.e12.
                        doi:10.1016/j.ccell.2022.10.022


                   130. Pantel K, Alix-Panabières C. Liquid biopsy and minimal residual disease — latest
                        advances  and  implications  for  cure.  Nat  Rev  Clin  Oncol.  2019;16(7):409-424.
                        doi:10.1038/s41571-019-0187-3


                   131. Chen H, Zhou Q. Detecting liquid remnants of solid tumors treated with curative
                        intent: circulating tumor DNA as a biomarker of minimal residual disease (review).
                        Oncol Rep. 2023;49(5):1-13. doi:10.3892/or.2023.8543

                   132. Gauri  S, Ahmad  MR.  ctDNA  detection  in  microfluidic  platform:  a  promising
                        biomarker for personalized cancer chemotherapy. J Sens. 2020;2020(1):8353674.
                        doi:10.1155/2020/8353674


                   133. Wan  JCM,  Massie  C,  Garcia-Corbacho  J,  et  al.  Liquid  biopsies  come  of  age:
                        towards  implementation  of  circulating  tumour  DNA.  Nat  Rev  Cancer.
                        2017;17(4):223-238. doi:10.1038/nrc.2017.7

                   134. Pekin D, Skhiri Y, Baret JC, et al. Quantitative and sensitive detection of rare
                        mutations using droplet-based microfluidics. Lab Chip. 2011;11(13):2156-2166.
                        doi:10.1039/C1LC20128J

                   135. He M, Crow J, Roth M, Zeng Y, Godwin AK. Integrated immunoisolation and
                        protein analysis of circulating exosomes using microfluidic technology. Lab Chip.
                        2014;14(19):3773-3780. doi:10.1039/C4LC00662C


                   136. Das  J,  Ivanov  I,  Sargent  EH,  Kelley  SO.  DNA  Clutch  Probes  for  Circulating
                        Tumor  DNA  Analysis.  J  Am  Chem  Soc.  2016;138(34):11009-11016.
                        doi:10.1021/jacs.6b05679

                   137. Im  YR,  Tsui  DWY,  Diaz  LA,  Wan  JCM.  Next-generation  liquid  biopsies:
                        embracing  data  science  in  oncology.  Trends  Cancer.  2021;7(4):283-292.
                        doi:10.1016/j.trecan.2020.11.001


                                                            42
   38   39   40   41   42   43   44   45   46   47   48